U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C21H24N2O3S
Molecular Weight 384.492
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LB-50016

SMILES

O=C1N(CCCCN2CCC(C2)C3=CC=CC=C3)S(=O)(=O)C4=C1C=CC=C4

InChI

InChIKey=YRBNPVDPNYJOMH-UHFFFAOYSA-N
InChI=1S/C21H24N2O3S/c24-21-19-10-4-5-11-20(19)27(25,26)23(21)14-7-6-13-22-15-12-18(16-22)17-8-2-1-3-9-17/h1-5,8-11,18H,6-7,12-16H2

HIDE SMILES / InChI

Molecular Formula C21H24N2O3S
Molecular Weight 384.492
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Tue Apr 01 16:24:15 GMT 2025
Edited
by admin
on Tue Apr 01 16:24:15 GMT 2025
Record UNII
TYH6YD5DX4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LB-50016
Code English
1,2-Benzisothiazol-3(2H)-one, 2-[4-(3-phenyl-1-pyrrolidinyl)butyl]-, 1,1-dioxide
Preferred Name English
2-[4-(3-Phenyl-1-pyrrolidinyl)butyl]-1,2-benzisothiazol-3(2H)-one 1,1-dioxide
Systematic Name English
2-[4-(3-Phenylpyrrolizino)butyl]-3-oxo-2,3-dihydro-1,2-benzisothiazole 1,1-dioxide
Systematic Name English
LB50016
Code English
Code System Code Type Description
PUBCHEM
10068602
Created by admin on Tue Apr 01 16:24:15 GMT 2025 , Edited by admin on Tue Apr 01 16:24:15 GMT 2025
PRIMARY
FDA UNII
TYH6YD5DX4
Created by admin on Tue Apr 01 16:24:15 GMT 2025 , Edited by admin on Tue Apr 01 16:24:15 GMT 2025
PRIMARY
CAS
228579-02-0
Created by admin on Tue Apr 01 16:24:15 GMT 2025 , Edited by admin on Tue Apr 01 16:24:15 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY